These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 28867761
21. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. Xue Y, Xu W, Zhao W, Wang W, Zhang D, Wu P. Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397 [Abstract] [Full Text] [Related]
22. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer. Shao B, Feng Y, Zhang H, Yu F, Li Q, Tan C, Xu H, Ying J, Li L, Yang D, Peng W, Tang J, Li S, Ren G, Tao Q, Xiang T. J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730 [Abstract] [Full Text] [Related]
23. Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation. Liu T, Wang J, Sun L, Li M, He X, Jiang J, Zhou Q. Cell Cycle; 2021 Aug; 20(16):1603-1616. PubMed ID: 34313525 [Abstract] [Full Text] [Related]
24. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer. Pradhan N, Parbin S, Kar S, Das L, Kirtana R, Suma Seshadri G, Sengupta D, Deb M, Kausar C, Patra SK. Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1651-1665. PubMed ID: 30954555 [Abstract] [Full Text] [Related]
25. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. Lin YC, Lee YC, Li LH, Cheng CJ, Yang RB. J Cell Sci; 2014 Jan 01; 127(Pt 1):85-100. PubMed ID: 24213532 [Abstract] [Full Text] [Related]
26. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene. Lam S, Wiercinska E, Teunisse AF, Lodder K, ten Dijke P, Jochemsen AG. Breast Cancer Res Treat; 2014 Nov 01; 148(1):7-18. PubMed ID: 25257729 [Abstract] [Full Text] [Related]
27. CLDN6 inhibits breast cancer cell malignant behavior by suppressing ERK signaling. Lu Y, Shao Y, Xie Y, Qu H, Qi D, Dong Y, Jin Q, Wang L, Wei J, Quan C. Cell Signal; 2022 Sep 01; 97():110393. PubMed ID: 35752352 [Abstract] [Full Text] [Related]
30. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152. Li Z, Li Y, Li Y, Ren K, Li X, Han X, Wang J. J Biochem Mol Toxicol; 2017 Sep 01; 31(9):. PubMed ID: 28544374 [Abstract] [Full Text] [Related]
31. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition. Prasad CP, Chaurasiya SK, Guilmain W, Andersson T. J Exp Clin Cancer Res; 2016 Sep 13; 35(1):144. PubMed ID: 27623766 [Abstract] [Full Text] [Related]
32. NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells. Xia B, Hou L, Kang H, Chang W, Liu Y, Zhang Y, Ding Y. BMC Cancer; 2020 Jul 06; 20(1):626. PubMed ID: 32631390 [Abstract] [Full Text] [Related]
40. A TGFBR2/SMAD2/DNMT1/miR-145 negative regulatory loop is responsible for LPS-induced sepsis. Ma F, Li Z, Cao J, Kong X, Gong G. Biomed Pharmacother; 2019 Apr 05; 112():108626. PubMed ID: 30784922 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]